Pfizer Inc. and BioNTech SE said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus. The companies said that tests of blood from people who had received only two doses found much lower levels of antibodies […]